Become part of Researchalize

News & Articles

Vaccini. A Siena inaugurato European Vaccine Hub per migliorare la preparazione sanitaria in tutta l’Ue

22/05/2025

Health Policy

Vaccini. A Siena inaugurato European Vaccine Hub per migliorare la preparazione sanitaria in tutta l’UE

L'iniziativa prevede azioni chiave che, tra le altre, accelereranno lo sviluppo di un vaccino a meno di 4 mesi dall'identificazione della sequenza genomica di un agente patogeno. Il progetto EVH è finanziato dall'Autorità per la Preparazione e la Risposta alle Emergenze Sanitarie (HERA) della Commissione Europea attraverso il programma EU4Health, con un importo fino a 102 milioni di euro.

News & Articles

18/04/2025

Research

Using lentiviral vectors to vaccinate against liver metastases

Liver metastases, which arise from different kinds of tumors, including colorectal cancer and melanoma, remain an unmet clinical need, as they poorly respond to current pharmacological strategies aimed at activating the endogenous anti-cancer immune response.

News & Articles

WHO announces priority endemic pathogens for urgent vaccine development

08/11/2024

Research

WHO announces priority endemic pathogens for urgent vaccine development

A World Health Organization (WHO) study has listed the top endemic pathogens for which new vaccines are 'urgently needed'.

News & Articles

UCLA launches study of personalised cancer vaccine in paediatric brain tumours

22/08/2024

Research

UCLA launches study of personalised cancer vaccine in paediatric brain tumours

H3 G34-mutant diffuse hemispheric gliomas are brain tumours commonly found in adolescents and young adults.

News & Articles

Beyfortus approved in China for the prevention of RSV disease in infants

02/01/2024

Our Network

Beyfortus approved in China for the prevention of RSV disease in infants

First and only RSV preventive option authorised for use in China

News & Articles

Mimicking nature: Virus-like particles and the next generation of vaccines

11/12/2023

Our Network

Mimicking nature: Virus-like particles and the next generation of vaccines

The ever-evolving infectious disease landscape requires researchers to move quickly to adapt and develop solutions to prevent people from experiencing severe outcomes of disease.

News & Articles

14/11/2023

Research

New WHO initiative to prioritise endemic pathogens for vaccine development

Value profiles of 16 pathogens with vaccines in clinical development will be featured.
The World Health Organization (WHO) has commissioned 16 ‘Vaccine Value Profiles (VVPs)’ to prioritise key endemic pathogens to accelerate vaccine development.

News & Articles

24/10/2023

Our Network

US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FluMist Quadrivalent

Potential to be the first and only self-administered flu vaccine.

News & Articles

13/10/2023

Our Network

Large real-world evidence studies reveal disproportionate burden of COVID-19 on the immunocompromised

Data covering almost 30 million individuals show continued burden of disease;
immunocompromised individuals comprise approximately one quarter of all COVID-19
hospitalisations, ICU admissions and deaths.

News & Articles

11/10/2023

Our Network

AstraZeneca reinforces commitment to protecting the most vulnerable from serious infectious diseases at IDWeek 2023

Real-world data from INFORM study demonstrate increased risk of severe COVID-19
outcomes among all individuals with immunocompromising conditions
and highlight need for additional protection.

FluMist Quadrivalent data support the potential for a self-administered influenza vaccine to expand access to an important tool for prevention.

Vaccines

Health Policy

Research

Research

Research

Our Network

Our Network

Research

Our Network

Our Network

Our Network